Skip to main content

Table 1 Relationship between intratumoral PCSK9 expression and clinicopathological features of HCC patients

From: PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Variable PCSK9 expression p
Low High
Age (years)
 ≤ 50 23 14 0.851
 > 50 41 27  
Gender
 Female 10 5 0.624
 Male 54 36  
AFP (ng/ml)
 ≤ 20 25 19 0.461
 > 20 39 22  
Number of tumors
 Single 44 28 0.961
 Multiple 20 13  
Tumor size (cm)
 ≤ 5 43 14 0.001
 > 5 21 27  
Tumor cell differentiation
 I–II 45 30 0.752
 III–IV 19 11  
Microvascular invasion
 No 32 12 0.036
 Yes 32 29